Übersetzung für "Molecular marker" in Deutsch

This can be determined in the gel by a comparison with the control and the molecular weight marker.

As a molecular size marker, the standard S-17 (Sigma, St. Louis, USA) was used.

To this end, 0.3 ?g of homogeneous protein were chromatographed in a 10% strength SDS gel in parallel with Marker proteins having a known molecular weight (Rainbow marker).

DIG-labelled DNA molecular weight marker VIII (Boehringer Mannheim) was loaded onto a free lane as a length standard.

To determine the molecular weight, 0.3 ?g of homogeneous protein was chromatographed in a denaturizing 10% strength SDS gel in parallel with Marker proteins of a known molecular weight (Rainbow Marker).

This use as molecular marker was, however, limited to solid tissue samples, since the described results showed that the protein GBP-1 is a protein which is effective in the cell and which is located in the cytoplasma of the cell.

We are interested in partnering opportunities in the areas of haploid induction, molecular marker technologies as well as supporting digital solutions.

In addition, our group develops and establishes specific molecular marker systems for other research programs at the institute, to enable or facilitate answers to questions in other fields of wildlife biology, such as in the area of conservation genetics, e.g. for the identification of relatives in natural populations or among free ranging animals.

The proportion of KWS’ research activities devoted to the subareas of the molecular plant biology, marker development and genetic engineering is growing steadily.

As it is not possible to make the antibody-antigen binding reaction directly visible, one of the binding partners has to be chemically coupled with a molecular marker or “label” (exception: mass-sensitive biosensors based on surface plasmon resonance, grating couplers, quartz crystal microbalance, surface acoustic waves and similar techniques directly measure the molecular binding reaction in real time if one of the binding partners is immobilized on the sensitive surface.

First efforts identifying a molecular marker which shows an activation of the endothelial cells by means of the above-mentioned inflammatory cytokines in the tissue led to comparative studies of gene expression in cultivated endothelial cells under different activation conditions.

In 15% polyacrylamide gels the dimeric MP52m migrates at about 22 kD (theoretical molecular weight: 27.4 kD) and MP52His at about 24 kD (theoretical molecular weight: 29.6 kD) estimated from a molecular weight marker (see FIG. 1).

A particularly preferred involves an implantable article wherein the molecular recognition marker includes or consists of an RGD or cRGD sequence.

Restriction analysis of the isolated plasmid DNA and comparison of the resultant fragment lengths with DNA fragments of known length (DNA Molecular Weight Marker X, Roche Diagnostics GmbH, Mannheim, Germany) and with DNA fragments of plasmid pTET3 revealed that the transformed plasmid which imparts tetracycline resistance is the plasmid pTET3.

By restriction analysis of the isolated plasmid DNA and comparison with DNA fragments of known length (DNA Molecular Weight Marker X, Roche Diagnostics GmbH, Mannheim, Germany), the plasmid pSELF3-panD was isolated, which consists of the plasmid vector pSELF3-1 and the region of pND10 which encodes the panD gene.

This detection preferably takes place with use of at least one molecular marker per polymorphism, in particular per diagnostic polymorphism.

The term “molecular marker” relates to nucleotide sequences that are complementary or at least complementary to the greatest possible extent or homologous to genomic sequences, for example nucleic acids used as probes or primers.

Such knowledge, together with new scientific findings on genomic regions that contribute to the expression of a specific quantitative character, will enhance genetic selection and improvement activities with the help of new techniques based on molecular markers (Marker-assisted Selection – MAS, Genomic Selection – GS) for a quicker and safer genetic progress.

However, immunotherapy shows first promising results and the future can be seen in the individualized therapy on the basis of molecular and morphological marker.

At TEDMED Quyen Nguyen demonstrates how a molecular marker can make tumors light up in neon green, showing surgeons exactly where to cut.